Response by Elming et al to Letter Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure"

被引:0
|
作者
Elming, Marie Bayer [1 ]
Signorovitch, James [2 ]
Kober, Lars [1 ]
Thune, Jens Jakob [1 ,3 ]
机构
[1] Univ Copenhagen, Rigshosp, Dept Cardiol, Copenhagen, Denmark
[2] Anal Grp Inc, Boston, MA USA
[3] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark
关键词
D O I
10.1161/CIRCULATIONAHA.118.033772
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2190 / 2190
页数:1
相关论文
共 50 条
  • [1] Letter by Adabag et al Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure"
    Adabag, Selcuk
    Wininger, Michael
    Singh, Steve N.
    [J]. CIRCULATION, 2018, 137 (20) : 2188 - 2189
  • [2] Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure
    Elming, Marie Bayer
    Nielsen, Jens C.
    Haarbo, Jens
    Videbaek, Lars
    Korup, Eva
    Signorovitch, James
    Olesen, Line Lisbeth
    Hildebrandt, Per
    Steffensen, Flemming H.
    Bruun, Niels E.
    Eiskjaer, Hans
    Brandes, Axel
    Thogersen, Anna M.
    Gustafsson, Finn
    Egstrup, Kenneth
    Videbaek, Regitze
    Hassager, Christian
    Svendsen, Jesper Hastrup
    Hofsten, Dan E.
    Torp-Pedersen, Christian
    Pehrson, Steen
    Kober, Lars
    Thune, Jens Jakob
    [J]. CIRCULATION, 2017, 136 (19) : 1772 - 1780
  • [3] Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy
    Daubert, James P.
    Barnett, Adam S.
    [J]. JACC-HEART FAILURE, 2019, 7 (08) : 725 - 727
  • [4] Letter by Witte et al regarding article, "Implantable Cardioverter-Defibrillators in Tetralogy of Fallot"
    Witte, Klaus K.
    Pepper, Christopher B.
    Thomson, John D.
    English, Kate M.
    [J]. CIRCULATION, 2008, 118 (05) : E99 - E99
  • [5] Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy RESPONSE
    Kolodziejczak, Michalina
    Andreotti, Felicita
    Navarese, Eliano Pio
    [J]. ANNALS OF INTERNAL MEDICINE, 2018, 168 (03) : 234 - 235
  • [6] Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy
    Littmann, Laszlo
    [J]. ANNALS OF INTERNAL MEDICINE, 2018, 168 (03) : 233 - 233
  • [7] Response to letter regarding article, "Implantable Cardioverter-Defibrillators in Tetralogy of Fallot"
    Khairy, Paul
    Harris, Louise
    Barlow, Amanda
    Beauchesne, Luc
    Therrien, Judith
    Gordon, Elaine
    Muhll, Isabelle Vonder
    Chetaille, Philippe
    Gatzoulis, Michael A.
    Landzberg, Michael J.
    Fernandes, Susan M.
    Cecchin, Frank
    [J]. CIRCULATION, 2008, 118 (05) : E100 - E100
  • [8] Letter by Mareev et al Regarding Article, "Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women"
    Mareev, Yura
    Butcher, Charles
    Cleland, John G. F.
    [J]. CIRCULATION-HEART FAILURE, 2016, 9 (05)
  • [9] Letter by Simpson et al Regarding Article, "Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients"
    Simpson, Timothy F.
    Salazar, James W.
    Tseng, Zian H.
    [J]. CIRCULATION, 2019, 140 (18) : E742 - E743
  • [10] Response to Letter Regarding Article, "Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women"
    Zeitler, Emily P.
    Hellkamp, Anne S.
    Schulte, Phillip J.
    Fonarow, Gregg C.
    Hernandez, Adrian F.
    Peterson, Eric D.
    Sanders, Gillian D.
    Yancy, Clyde W.
    Al-Khatib, Sana M.
    [J]. CIRCULATION-HEART FAILURE, 2016, 9 (05)